Literature DB >> 25495170

Trends in survival outcomes of B-lineage acute lymphoblastic leukemia in elderly patients: analysis of Surveillance, Epidemiology, and End Results database.

Guru Subramanian Guru Murthy1, Raji Venkitachalam2,3, Paulette Mehta4.   

Abstract

B-lineage acute lymphoblastic leukemia (B-ALL) in the elderly population is generally considered to have a poor prognosis. It is unclear whether their survival has improved in the current era. Using the Surveillance, Epidemiology, and End Results database, we selected 717 elderly patients (age≥60) with B-ALL diagnosed between 1992 and 2011. Overall survival (OS) was compared based on their period of diagnosis and age. Patients in the age group 60-69 had an improvement in OS over time, both 1-year OS (49.4% in 2002-2011 vs. 33.1% in 1992-2001) and 5-year OS (20.4% in 2002-2011 vs. 8.1% in 1992-2001, p=0.002). Patients≥70 years had no significant improvement in 1-year OS or 5-year OS (5-year OS 5.5% in 1992-2001 vs. 9.7% in 2002-2011, p=0.326). Hence, there are discrepancies in the improvement of OS among elderly patients with B-ALL. Further focus of research in elderly patients with B-ALL is needed to improve their outcome.

Entities:  

Keywords:  Elderly; SEER; acute lymphoblastic leukemia; survival

Mesh:

Year:  2015        PMID: 25495170     DOI: 10.3109/10428194.2014.991921

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

Review 1.  [Acute leukemia in adults].

Authors:  E Eigendorff; A Hochhaus
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 2.  Treatment of older patients with acute lymphoblastic leukemia.

Authors:  Nicola Gökbuget
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 3.  Treatment of Older Patients with Acute Lymphoblastic Leukaemia.

Authors:  Nicola Gökbuget
Journal:  Drugs Aging       Date:  2018-01       Impact factor: 3.923

Review 4.  Recent advances and novel treatment paradigms in acute lymphocytic leukemia.

Authors:  Nikolaos Papadantonakis; Anjali S Advani
Journal:  Ther Adv Hematol       Date:  2016-06-29

5.  Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

Authors:  A G Dinmohamed; A Szabó; M van der Mark; O Visser; P Sonneveld; J J Cornelissen; M Jongen-Lavrencic; A W Rijneveld
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

6.  Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.

Authors:  Emma Lennmyr; Karin Karlsson; Lucia Ahlberg; Hege Garelius; Erik Hulegårdh; Antonio S Izarra; Joel Joelsson; Piotr Kozlowski; Andreea Moicean; Beata Tomaszewska-Toporska; Anna Lübking; Helene Hallböök
Journal:  Eur J Haematol       Date:  2019-06-06       Impact factor: 2.997

Review 7.  Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)-Gene Rearrangements.

Authors:  Alexia Tsakaneli; Owen Williams
Journal:  Front Pharmacol       Date:  2021-09-14       Impact factor: 5.810

8.  Real-world outcomes in elderly ALL patients with and without allogeneic hematopoietic stem cell transplantation: a single-center evaluation over 10 years.

Authors:  Kevin D Hofer; Urs Schanz; Rahel Schwotzer; Gayathri Nair; Markus G Manz; Corinne C Widmer
Journal:  Ann Hematol       Date:  2022-02-19       Impact factor: 3.673

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.